Assistive Soft Robotic Glove (EsoGLOVE) Intervention for Stroke Patients

Launched by NATIONAL UNIVERSITY HOSPITAL, SINGAPORE · Aug 8, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new device called the EsoGLOVE, which is a soft robotic glove designed to help stroke patients improve their hand function. Stroke can lead to difficulties with movement and coordination in the hands, making it hard for survivors to perform daily tasks and enjoy a good quality of life. The trial aims to see if the EsoGLOVE, combined with special sensors that provide feedback, can help patients regain their hand function more effectively than traditional therapy alone. Researchers believe that using this device during rehabilitation may help patients recover better and faster by allowing them to practice hand exercises more independently.

To be eligible for this trial, participants should be between 30 and 90 years old and have experienced a stroke, either ischemic (caused by a blocked blood vessel) or hemorrhagic (caused by bleeding in the brain). They must be stable enough to participate in therapy and have some movement impairment in one arm. Participants will be required to give consent and be able to follow instructions during the study. While the trial is not yet recruiting, it will assess how well the EsoGLOVE can help stroke patients improve their hand function and overall recovery during their hospital rehabilitation.

Gender

All

Eligibility criteria

• Inclusion Criteria:
• • Aged 30-90 years regardless of lesion size, race
• • Stroke type: ischemic or haemorrhagic
• • Medically stable conditions
• • Fugl-Meyer Assessment (FMA) of upper extremity impairment of 10-56 out of 66.
• • Able to give own consent, comprehend and follow commands
• • Able to sit upright and maintain sitting balance for at least 30 minutes
• • Able to stay alert and focus on the tasks for at least 30 minutes and more.
• • Unilateral upper limb impairment
• Exclusion Criteria:
• • Recurrent stroke
• • Unstable medical conditions (e.g. heart attack, unstable blood pressure, infection, and etc.) or anticipated life expectancy of <1 year.
• • Cognitive and communicative impairment (e.g. severe aphasia, inattention, learning difficulty, and etc).
• • History of severe depression or active psychiatric disorder.
• • Severe spasticity (Modified Ashworth scale =2), joint contractures or deformity, poor skin conditions (e.g. irritated skin, open wounds), amputation of fingers, and allergic condition (e.g. patients with allergies to adhesive gel).
• • Poor trunk control or postural hypotension.